PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

TRIAL Holdings, Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

TRIAL Holdings, Inc. owes ¥0.83 for every ¥1 it owns. Net profit fell 70% in the year to Jun 2026, and shrank 24% a year on average over 3 years.

Compared with Consumer Defensive companies in Japan · latest annual results Jun 2026.

P/E ratio

133.3

Investors pay ¥133.3 for every ¥1 of TRIAL Holdings, Inc.'s yearly profit, higher than 97% of Consumer Defensive companies in Japan.

P/B ratio

3.50

The share price is 3.50 times TRIAL Holdings, Inc.'s book value per share, higher than 94% of Consumer Defensive companies in Japan.

Market cap

¥458.0 B

The total market value of all of TRIAL Holdings, Inc.'s shares at today's price (share price × number of shares), larger than 90% of Consumer Defensive companies in Japan. PosiCap size class: Meso Cap.

Net worth (book value)

¥130.9 B

What TRIAL Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥1,066

Net worth divided by the number of shares. The share price of ¥3,730 is 3.5 times this, which is the P/B above.

Return on equity (ROE)

3.1%

TRIAL Holdings, Inc. earned 3.1% on its shareholders' money over the last year, lower than 81% of Consumer Defensive companies in Japan.

Owes vs Owns

0.83×

TRIAL Holdings, Inc. owes ¥0.83 for every ¥1 it owns (high), higher than almost all Consumer Defensive companies in Japan.

Dividend yield

0.47%

TRIAL Holdings, Inc. pays 0.47% of its share price as dividends a year, lower than 98% of dividend-paying Consumer Defensive companies in Japan.

Revenue growth

+68%

Revenue rose 68% in the year to Jun 2026, and grew 27% a year on average over 3 years.

Profit growth

-70%

Net profit fell 70% in the year to Jun 2026, and shrank 24% a year on average over 3 years.

Profit margin

0.3%

TRIAL Holdings, Inc. keeps ¥0 of every ¥100 of revenue as net profit.

Cash quality

26.1×

Cash from TRIAL Holdings, Inc.'s business was 26.1× its reported profit in the year to Jun 2026 — its profit turned into cash.

Interest cover

7.1×

TRIAL Holdings, Inc.'s operating profit covered its interest costs 7.1 times in the year to Jun 2026.

Cash vs debt

Net debt

TRIAL Holdings, Inc. had ¥325.5 B more debt than cash (net debt) at Jun 2026.

Questions

What is TRIAL Holdings, Inc.'s P/E ratio?

Investors pay ¥133.3 for every ¥1 of TRIAL Holdings, Inc.'s yearly profit, higher than 97% of Consumer Defensive companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For TRIAL Holdings, Inc.: ¥458.0 B ÷ ¥130.9 B (30 Jun 2026) = 3.5.

What is TRIAL Holdings, Inc.'s return on equity?

TRIAL Holdings, Inc. earned 3.1% on its shareholders' money over the last year, lower than 81% of Consumer Defensive companies in Japan.

How much does TRIAL Holdings, Inc. owe compared with what it owns?

TRIAL Holdings, Inc. owes ¥0.83 for every ¥1 it owns (high), higher than almost all Consumer Defensive companies in Japan.

Does TRIAL Holdings, Inc. pay a dividend?

Yes. TRIAL Holdings, Inc. pays 0.47% of its share price as dividends a year, lower than 98% of dividend-paying Consumer Defensive companies in Japan.

Is TRIAL Holdings, Inc.'s revenue growing?

Revenue rose 68% in the year to Jun 2026, and grew 27% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.